Diabetes Researchers Say FDA Is Slowing Artificial Pancreas Efforts
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.S. is "desperately behind the curve," as a "result of regulatory policy that is just not working in the interest of people who live with type 1 diabetes," JDRF CEO says.